News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|September 1, 2001

Should we offer HRT to ovarian and endometrial cancer survivors? Yes.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Weekly review: Individualized TRT, acetaminophen safety reaffirmed, and more

ByJoshua Fitch, Senior Editor

June 6th 2026

Justin Drake, PhD, explains the Certitude Breast blood test for early breast cancer detection

Justin Drake, PhD, explains the Certitude Breast blood test for early breast cancer detection

ByJustin Drake, PhD

June 4th 2026

Clinical pearls into new postmenopausal guidelines from ACOG, with Susan Loeb-Zeitlin, MD, FACOG

Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG

BySusan E. Loeb-Zeitlin, MD, FACOG

June 4th 2026

SMFM in midst of first annual High-Risk Pregnancy Awareness Week | Image credit: Stock.adobe.com

SMFM in midst of first annual High-Risk Pregnancy Awareness Week

ByJoshua Fitch, Senior Editor

June 3rd 2026

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds | Image credit: Stock.adobe.com

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

ByJoshua Fitch, Senior Editor

June 3rd 2026

Latest CME

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – North Carolina

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – North Carolina

Girish Kunapareddy, MD; Sara M. Tolaney, MD, MPH

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Wyoming & Montana

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Wyoming & Montana

Yan Ji, MD; Neil M. Iyengar, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

Weekly review: Individualized TRT, acetaminophen safety reaffirmed, and more

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

Clinical pearls into ACOG's postmenopausal bleeding guidelines with Susan Loeb-Zeitlin, MD, FACOG

SMFM in midst of first annual High-Risk Pregnancy Awareness Week

Comorbidities associated with lower HRT uptake may reflect overcautious prescribing